Features
• Chronic fibrosing interstitial lung disease from asbestos fibre inhalation
• Lower zone predominant fibrosis
• Long latency period (20–40 years)
Clinical
• Progressive dyspnoea
• Dry cough
• Fine bibasal crackles
• Clubbing common
Imaging
• CXR: basal reticulonodular shadowing, pleural plaques
• HRCT: honeycombing, subpleural fibrosis
Risks
• Bronchogenic carcinoma (risk amplified by smoking)
• Mesothelioma (pleural malignancy, independent of smoking)
• Localised areas of pleural fibrosis with calcifications
• Marker of prior asbestos exposure
• Usually asymptomatic and benign
• Small upper lobe nodules
• Usually asymptomatic
• Confluent upper lobe masses
• Dyspnoea, pulmonary hypertension
• Long-term coal dust exposure
• Often coexists with rheumatoid arthritis (Caplan’s syndrome: large rheumatoid nodules in lungs)
Features
• Upper lobe predominant nodular fibrosis
• Occupational exposure: mining, quarrying, sandblasting
Imaging
• CXR: multiple small nodules, upper zones
• Eggshell calcification of hilar lymph nodes (classic clue)
Risks
• Markedly increased risk of TB reactivation
• Increased risk of lung cancer
Features
• Granulomatous lung disease resembling sarcoidosis
• Exposure: aerospace, electronics, nuclear, fluorescent lamp industries
Clinical
• Dyspnoea, cough, fatigue
• Non-caseating granulomas on biopsy
Diagnosis
• Beryllium lymphocyte proliferation test
Features
• Hypersensitivity reaction to cotton dust, textile industry
Clinical
• "Monday chest tightness" (symptoms worse at start of work week, improve over weekend)
• Progressive dyspnoea over years
Features
• Variable airflow obstruction and airway hyperresponsiveness
• Triggers: flour dust (bakers), isocyanates (spray painters), laboratory animal proteins
Diagnostic clues
• Improvement on weekends or holidays
• Peak flow monitoring at work vs home
Management
• Remove exposure
• Standard asthma treatment
Features
• Acute onset asthma-like symptoms following single high-level irritant exposure (e.g., chemical spill)
Distinctive points
• No latency or sensitisation period
• May become chronic
Extra Revision Pearls
• Lower lobe fibrosis → asbestosis, IPF
• Upper lobe fibrosis → CWP, silicosis, TB, sarcoidosis
• Asbestosis + smoking → greatly increases lung carcinoma risk (especially squamous cell)
• Eggshell calcification → classic exam clue for silicosis
• Caplan’s syndrome → CWP + rheumatoid arthritis nodules
• Mesothelioma → pleural-based tumour; does not require smoking cofactor
• RADS → no latency, unlike classic occupational asthma which needs sensitisation
————————————————————————————————————————————————————————————————————————————————————————————————————————-
Author & Educational Disclaimer
Author:
Dr Phillip Cockrell BM FRCP DipClinEd
Dr Phillip Cockrell is a UK Consultant Physician in Internal Medicine, currently working at Queen Alexandra Hospital, Portsmouth University Hospitals NHS Trust. He has previously worked as a registrar across Intensive Care Medicine, Gastroenterology, Cardiology, Stroke Medicine, Acute Medicine, and Respiratory Medicine.
He has held senior leadership roles including Associate Clinical Director of the Acute Medical Unit, Clinical Director of Internal Medicine, and Chief of Medicine. Dr Cockrell has over 15 years’ experience in postgraduate medical education, having lectured extensively across the MRCP syllabus and contributed to MRCP revision teaching and course development.
Dr Cockrell holds a Bachelor of Medicine (BM), Fellowship of the Royal College of Physicians (FRCP), and a Diploma in Clinical Education (DipClinEd). His teaching approach is based on structured consolidation of complex medical topics to support efficient and effective revision for postgraduate examinations.
Purpose of this content:
The material on this page is intended solely for educational purposes to support revision for the MRCP (UK) Part 1 examination. It reflects examination-relevant principles of internal medicine and is designed to aid learning and pattern recognition.
Medical disclaimer:
This content is designed for postgraduate medical examination revision and does not constitute medical advice, diagnosis, or treatment guidance and must not be used as a substitute for professional clinical judgement, local guidelines, or specialist consultation. Clinical decisions should always be made in the context of individual patient circumstances and current national guidance.